Atea Pharmaceuticals, Inc.

AVIR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 55 employees
71
SEC Filings
$5.28
Close 2026-09-23
55
Employees

Business Summary

Atea Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on discovering, developing, and commercializing novel orally administered antivirals. Its lead program is the combination regimen of bemnifosbuvir and ruzasvir for hepatitis C virus (HCV) treatment, currently in Phase 3 trials (C-BEYOND and C-FORWARD). It is also developing AT-587, a potential first direct-acting antiviral for chronic hepatitis E virus (HEV) infection, targeting immunocompromised patients, with a Phase 1 study anticipated in mid-2026.

Latest Stock Quote

AVIR 2026-09-23 $5.28 O:$5.6 H:$5.6 L:$5.25 Vol:0.2M VWAP:$5.3409
origin leaf: null

Next Earnings

expected 2026-11-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-094159EDGAR101K words
2025-03-062024-12-310000950170-25-034808EDGAR96K words
2024-02-282023-12-310000950170-24-022226EDGAR105K words
2023-02-282022-12-310000950170-23-005186EDGAR114K words
2022-02-282021-12-310001564590-22-007672EDGAR—
2021-03-302020-12-310001564590-21-016724EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001193125-26-347021EDGAR67K words
2025-11-122025-09-300001193125-25-277815EDGAR67K words
2025-08-072025-06-300000950170-25-105123EDGAR66K words
2025-05-122025-03-310000950170-25-069367EDGAR64K words
2024-11-072024-09-300000950170-24-123447EDGAR64K words
2024-08-072024-06-300000950170-24-092914EDGAR69K words
2024-05-142024-03-310000950170-24-059699EDGAR67K words
2023-11-082023-09-300000950170-23-061213EDGAR71K words
2023-08-082023-06-300000950170-23-039920EDGAR70K words
2023-05-082023-03-310000950170-23-018869EDGAR67K words
2022-11-072022-09-300000950170-22-022699EDGAR—
2022-08-082022-06-300000950170-22-015570EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001193125-26-346888EDGAR3K words
2026-03-050001193125-26-093961EDGAR4K words
2026-01-080001193125-26-007081EDGAR2K words
2025-11-120001193125-25-277627EDGAR4K words
2025-08-070001193125-25-175433EDGAR3K words
2025-06-200001193125-25-143750EDGAR1K words
2025-05-120001193125-25-117809EDGAR3K words
2025-04-170001193125-25-083523EDGAR1K words
2025-04-010001193125-25-069932EDGAR1K words
2025-03-240001193125-25-060794EDGAR1K words

71 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

hepatitis-c-virus-(hcv)-treatment hepatitis-e-virus-(hev)-treatment antiviral-therapeutics immunocompromised-patient-care nucleos(t)ide-analog-prodrug-platform rna-dependent-rna-polymerase-(rdrp)-inhibition fixed-dose-combination-(fdc)-tablet-formulation direct-acting-antiviral-(daa)-development

Company Identity

CIK0001593899
TickerAVIR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedMA
Websitehttps://www.ateapharma.com
Listed2020-10-30

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 8ac9854dcf1a34d1bb704a05808f4c66c120d1542f5cf8db9150d21ec984e373
parent: 80ebb1921877310fa7cdf329ff9fcab0e47d63ed2e69cfb67b03d4953a8434fc
content hash: 021959a3938008552266d4d11d21e60b2af60891bf4e30f705bfd6e8d7fafb68
signed: 2026-09-29T12:00:25.965Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AVIR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AVIR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AVIR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.